Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEMA5A antisense RNA 1 (SEMA5A-AS1) is a long noncoding RNA gene located on chromosome 5p15.31, transcribed antisense to the SEMA5A locus. Like other lncRNAs, it may regulate gene expression through epigenetic, transcriptional, or post-transcriptional mechanisms. There is currently no direct evidence for disease association, biological function, or drug interaction for SEMA5A-AS1. Most available studies focus on the protein-coding SEMA5A gene—an axon guidance membrane protein implicated in neurodevelopmental disorders and cancer—rather than the antisense noncoding transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEMA5A antisense RNA 1 (SEMA5A-AS1).